Phase 2 Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 65 years of age.
- People who have had genetic testing that found a change in the PRKAG2 gene, classified as disease-causing, likely disease-causing, or of uncertain significance.
- People who have symptoms or signs consistent with a condition called PRKAG2 Syndrome.
- People who are able and willing to follow all study procedures as required.
- People who are able and willing to undergo a procedure where a small tissue sample is taken from the heart muscle (this applies to Part A of the study).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or currently breastfeeding.
- People who have significant problems with their liver, kidneys, blood, or heart that could increase the risks of taking part in the study.
- People with very severe heart failure (classified as NYHA Class IV) or whose heart is pumping at less than 45% of its normal capacity.
- People who have recently had a significant heart-related health event or procedure (confirm with trial site for specific timeframes).
- People who have previously been treated with certain experimental therapies or a type of genetic medicine called oligonucleotide therapies within time periods defined by the study protocol.
- People who have any other condition that, in the opinion of the study doctor, may affect their suitability to participate (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 283-227-6543
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 4 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.